Clinical trials: Trauma Coagulopathy

Trauma

Pragmatic, Randomized Optimal Platelet and Plasma Ratios

• Completed
• Age: 15 years and older
• Phase 3
• Results posted

Pragmatic, Randomized, Optimal Platelet and Plasma Ratios (PROPPR)is a Phase III trial designed to evaluate the difference in 24-hour and 30-day mortality among subjects predicted to receive massive transfusion ([MT] (defined as…

Trial name

PROPPR (NCT01545232)

Testing

1:1:1 Blood Transfusion Ratio, 1:1:2 Blood Transfusion Ratio

Where

12 sites in United States, Canada

Volunteers

680 people

Sponsor

The University of Texas Health Science Center, Houston